3rd World Cancer Congress - 2019
3rd World Cancer Congress - 2019 | Mumbai
Early Bird Registration Closes: 15th June, 2019 Abstract Submission Closes: 27th June, 2019
3rd World Cancer Congress - 2019 3rd World Cancer Congress - 2019


Arjyopa Healthcare and Raytheon Healthcare welcomes you to attend the 3rd World Cancer Congress - 2019 during November 20 - 21, 2019 at Mumbai, India. We cordially invite all the participants interested in sharing their knowledge and research in the arena of Oncology and Cancer Research.

We expect thousands of worldwide cancer and health experts to converge to our capital city in September 2019, and take advantage of this major educational platform to further 'Strengthen. Inspire. Deliver’ the global cancer control momentum.

From feedback received, the previous Congresses resulted in fruitful collaborations and rewarding experiences for the delegates who left the events with concrete tools and solutions that helped them enhance their work practice and impact. As hosts, we already feel very excited to create the same energetic and inspiring atmosphere during the Congress week in Mumbai, adding local flavors and new perspectives such as the role of complementary treatment in cancer to the programme.

We are also hopeful that through the Congress our community in Asia will be able to increase awareness about the growing cancer burden that affects our region and strengthen its ties to further tackle the disease. Studies estimate that 8.1 million people in Asia will die of cancer by 2020 - 75% of which will be unable to face the huge medical care costs within their first year of diagnosis.

Thus, the urgent need to mobilise our efforts, promote cancer advocacy more efficiently and develop effective national policies and plans for prevention, early detection, care and support

We look forward to the honor of welcoming you in Mumbai, India.

With Warm Regards

Partha J. Das

Convenor, Organizing Team

CEO and Co-Founder, Raytheon Healthcare

Aruna Das

Convenor, Organizing Team

CEO and Co-Founder, Arjyopa Healthcare

3rd World Cancer Congress - 2019

Chairman Message

Worldwide Cancer Diagnostics advertise is relied upon to develop from $8.54 billion out of 2016 to reach $22.41 billion by 2023 with a CAGR of 8 %. Expanding frequency of cancer illnesses, developing mindfulness about human services, and later mechanical progressions in symptomatic gadgets are a portion of the elements moving the market development. Moreover, ideal government repayment approaches, expanding interests in innovative work exercises are some different elements boosting the market development amid the estimated time frame.
Then again, high expenses of analytic gadgets, strict controls for new item endorsements are the variables restricting the market development. Just 10% of patients determined to have a harmful neoplasm get by for over five years. Colorectal cancer (of the colon and rectum), the most widely recognized threatening tumor in the event that we amass people together, presents a normal survival rate of 50-55% five years after analysis, implying that a large portion of the patients survives this type of cancer. Prostate cancer, today the most widely recognized tumor in men, has an inexorably great prognosis, with a worldwide survival rate of 76%, which is higher in youthful grown-ups. Ovarian cancer displays an exceptionally shifted prognosis relying upon age: while 70% of the gathering somewhere in the range of 15 and 44 years survives this type of cancer, this is the situation for just 19% of those more than 74 years of age. Consistently omics arranges cancer gatherings in Europe.
This 3rd World Cancer Congress 2019 conference will be organized around the theme “Cancer in a New Way: Innovation, Prevention, Diagnosis & Cure”. This conference is the best opportunity for those who have centered their focus on the cancer research and want to share it with the rest of the world. Presentations, distribution of information, meetings with current and potential scientists, discussions on new developments and research, and receiving recognition at this event are the main motive of this conference. Renowned speakers all over the globe are welcomed to talk about their researches and developments, and also discuss the latest updates and new techniques for the treatment and surgery involved in oncology are hallmarks of this cancer conference.
I sincerely hope that this conference will deliberate and discuss all the different facets of this exciting topic and come up with recommendations that will lead to a better, healthier, merrier world.
I wish the conference great success.

With Warm Regards

Padmashri Dr. Ramakant Krishnaji Deshpande


Asian Cancer Institute

3rd World Cancer Congress - 2019

Co-Chairman Message

On behalf of the organizing committee, it is a great privilege to extend my invitation to all of you to the 3rd World Cancer Congress-2019 to be held on 20th and 21st of November 2019 at Mumbai. The theme for this year’s conference is “Cancer in a New Way: Innovation, Prevention, Diagnosis and Cure”. The meeting has been conceptualized as an international health care summit that will bring under a common umbrella, two major topics: cancer, and drug development and discovery. The meeting will provide a unique platform for scientists across geographies to share their insights on emerging challenges in cancer therapy, management, and novel therapeutic approaches. In a rapidly changing clinical landscape, cancer emerges as a phenotypically diverse and heterogeneous ailment, where tumor microenvironment mimicking global ecosystem limits the success of existing treatment paradigms. On one hand, drug discovery and development in an era of personalized medicine is affected owing to lack of proper preclinical de-risking tools. Further compounding this diminishing return, there is a shortage of effective therapeutics with low toxicities and affordable prices, which together hinder the rationalization of therapy combinations in the personalized settings. I believe that the upcoming summit will address these issues and help us to bridge the gap between different stakeholders while enabling to work towards a consensus statement.
We are particularly expecting active participation of young investigators and research students, besides established academic, industry and business leaders, for making the conference a truly stimulating event.
The scientific program this year is intended to cover a spectrum of topics such as cancer awareness, social and economic challenges, complementary medicines, tumor microenvironment, biomarkers, preclinical disease models, emerging treatment paradigms like immunotherapy, precision therapy, and challenges pertaining to drug discovery, development, and transitional research.
The two-day long conference has been scheduled to have sessions covering key note address, plenary lectures, invited and oral presentations. This year the organizer has introduced two awards: Renato Dulbecco Memorial Award and Edward Keenedy Memorial Award that will be conferred to the best senior and young scientists of the conference, respectively.

With Warm Regards

Prof. Shubhada V. Chiplunkar


Advanced Centre for Treatment, Research & Education in Cancer (ACTREC)

3rd World Cancer Congress - 2019


Conference Secretariat
#6, Floor No-03, S.S. Group, UK Dutta Road, Gora Bazar, Dum Dum, Kolkata - 700028, WB, India
Ph: +91 9674546603 / +91 8431061984
E: [email protected] / [email protected]

16192 Coastal Hwy., Lewes, DE 19958, US
Ph: +1 (315) 830-2544
E: [email protected]

3rd World Cancer Congress - 2019


III World Cancer Congress - 2019

3rd World Cancer Congress - 2019

2019 - 2020 @WCC - [email protected]